UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development

Main Category: HIV / AIDS
Also Included In: Immune System / Vaccines
Article Date: 31 Jan 2010 - 1:00 PDT

Current ratings for:
'UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development'

Patient / Public:5 stars

4.6 (5 votes)

Healthcare Prof:5 stars

5 (1 votes)


UNAIDS strongly applauds today's announcement by the Bill & Melinda Gates Foundation to invest USD 10 billion into research and development of vaccines over the next 10 years.

The announcement, made at the World Economic Forum in Davos, is a welcome step forward in commitment to vaccine research, however large gaps in funding for the research and development of vaccines still remain.

"The best hope for ending the AIDS epidemic lies in a developing a vaccine," said Michel Sidibé, Executive Director of UNAIDS. "A vaccine for HIV would save millions of lives and I call on both governments and the private sector to follow this example and scale-up their commitment to this important area of work in health and development."

The long term response to the AIDS epidemic depends on progress in HIV prevention research and continued funding for scientific research and development. A vaccine for HIV still remains many years away and UNAIDS will continue to advocate to advance the research and development agenda at national, regional and global levels to bring the quest for a vaccine closer.

Source
UNAIDS

Article adapted by Medical News Today from original press release.
Visit our hiv / aids section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
UNAIDS. "UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development." Medical News Today. MediLexicon, Intl., 31 Jan. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/177649.php>

APA
UNAIDS. (2010, January 31). "UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/177649.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'UNAIDS Commends Commitment By The Bill & Melinda Gates Foundation To Advancing Vaccine Research And Development'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


HIV / AIDS

What Is AIDS? What Is HIV?

AIDS (Acquired immune deficiency syndrome or acquired immunodeficiency syndrome) is a disease caused by a virus called HIV (Human Immunodeficiency Virus). Read more...

Most Popular Articles



Follow Our HIV News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our HIV / AIDS Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »